skip to Main Content
SentreHEART United States
  • Home
  • For Patients
  • For Healthcare Professionals
  • About Us
    • Company
    • Leadership
    • Careers
    • Medical Advisory Board
  • Contact

About Us

Home » About Us

OUR COMPANY

LEARN MORE

LEADERSHIP

LEARN MORE

MEDICAL ADVISORY BOARD

LEARN MORE

CAREERS

LEARN MORE
  • Company
  • Leadership
  • Careers
  • Medical Advisory Board
  • Press Room
  • Contact
Recent Press & Events
  • SentreHEART Announces Initial Clinical Use of the LARIAT® with EpiRAILÔ Procedure for Left Atrial Appendage Exclusion August 5, 2019
  • Industry Expert Presentation in Rhythm Theater: Therapeutic Solutions for the Persistent Atrial Fibrillation Patient March 13, 2019

Products and therapies discussed on this website may not be available in all countries.

© 2020 SentreHEART, Inc. All rights reserved.
SentreHEART, LARIAT, EndoCATH, FindrWIRZ, SofTIP, TenSURE, and SureCUT are registered trademarks or trademarks of SentreHEART, Inc. All SentreHEART devices have received CE Mark certification. All SentreHEART devices are for investigational use only in the U.S. for the purpose of closing the LAA in Afib patients also receiving catheter ablation.

  • For Patients
  • For Healthcare Professionals
  • Terms of Use
  • Privacy
  • CA Privacy
  • Cookies
  • Press Room
  • Contact
By clicking "Okay" or continuing to use our site, you acknowledge that you accept our Website's Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible website experience. Learn more here.Okay!